BI 1265162

BI 1265162 · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BI 1265162, covering 2021-06-04 to 2022-07-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study in Healthy Men That Tests if Taking BI 1265162 by Mouth, Intravenously, or Inhaled Influences the Amount of BI 1265162 in the Blood [Phase 1]

See pricing